| 08.12.2021 19:31:07 | |
|---|---|
| Cena | |
| 144,14 EUR | |
| Změna | -0,47% (-0,68) |
Základní údaje
| ISIN | US4781601046 |
| Symbol | JNJ |
| Burza | Duesseldorf |
| Měna | EUR |
| Sektor | Chemical / Pharmaceutical / Health |
| Typ cenného papíru | Akcie |
| Tržní kapitalizace (mil.) | 383.888 EUR |
| Benchmark | S&P 500 |
Tržní data
| Nákup (částka) | - |
| Prodej (částka) | - |
| Otevírací cena | 144,70 EUR |
| Max | 144,84 EUR |
| Min | 144,00 EUR |
| Závěrečná cena (předchozí den) | 144,82 EUR |
| Cena vážená obchodovaným objemem | 105,314 EUR |
| Objem (kusy) | 4 |
| Obchodovaný objem | 576,00 |
| Počet obchodů | 11 |
| Poslední zobchodovaný počet | 0 |
Futures a opce
| Související Futures | 15 |
| Související Opce | - |
PDF ke stažení
| Report společnosti: JOHNSON & JOHNSON |  |
Stupnice: ABS REL
Nástroj/produkt
Přidat benchmark:
Minulá výkonnost nezaručuje výkonnost budoucí.Zdroj: FactSet
Aktuální analýzy a prognózy
| Datum | Nadpis | Stáhnout | |
| 01.12.2021 |
|
Global Equity Ratings |
|
| 05.11.2021 |
|
Global Equity Ratings |
|
| 03.11.2021 |
|
Global Equity Ratings |
|
| 19.10.2021 |
|
Global Equity Ratings |
|
| 29.09.2021 |
|
Global Equity Ratings |
|
Všechny burzy pro JOHNSON & JOHNSON
| Burza | Datum | Čas | Cena | Obchodovaný objem (mil.) | Počet obchodů |
| Xetra | 08.12.2021 | 17:35 | 144,02 EUR | 0,35 | 138 |
| Vienna Stock Exchange | 08.12.2021 | 17:32 | 144,00 EUR | 0,04 | 12 |
| Tradegate | 08.12.2021 | 22:26 | 144,82 EUR | 1,12 | 153 |
| Stuttgart | 08.12.2021 | 20:12 | 144,32 EUR | 0,02 | 11 |
| SIX Swiss Exchange | 15.11.2019 | 17:35 | 145,00 CHF | 0,00 | 1 |
| SIX Swiss Exchange | 30.03.2020 | 17:35 | 150,00 USD | 0,00 | 1 |
| NYSE | 08.12.2021 | 22:10 | 164,34 USD | 1.019,03 | 66.988 |
| Munich | 08.12.2021 | 14:37 | 144,72 EUR | 0,01 | 2 |
| London Stock Exchange | 08.12.2021 | 17:35 | 165,00 USD | 0,01 | 10 |
| Hanover | 08.12.2021 | 08:01 | 144,88 EUR | 0,00 | 1 |
| Hamburg | 08.12.2021 | 08:01 | 144,88 EUR | 0,00 | 1 |
| Frankfurt | 08.12.2021 | 21:05 | 144,44 EUR | 0,07 | 12 |
| Duesseldorf | 08.12.2021 | 19:31 | 144,14 EUR | 0,00 | 11 |
| Berlin | 08.12.2021 | 08:08 | 144,66 EUR | 0,00 | 1 |
| 08.12.2021 19:31:07 | |
|---|---|
| Cena | |
| 144,14 EUR | |
| Změna | -0,47% (-0,68) |
Základní údaje
| ISIN | US4781601046 |
| Symbol | JNJ |
| Burza | Duesseldorf |
| Měna | EUR |
| Sektor | Chemical / Pharmaceutical / Health |
| Typ cenného papíru | Akcie |
| Tržní kapitalizace (mil.) | 383.888 EUR |
| Benchmark | S&P 500 |
Tržní data
| Nákup (částka) | - |
| Prodej (částka) | - |
| Otevírací cena | 144,70 EUR |
| Max | 144,84 EUR |
| Min | 144,00 EUR |
| Závěrečná cena (předchozí den) | 144,82 EUR |
| Cena vážená obchodovaným objemem | 105,314 EUR |
| Objem (kusy) | 4 |
| Obchodovaný objem | 576,00 |
| Počet obchodů | 11 |
| Poslední zobchodovaný počet | 0 |
Výkonnost a riziko
| 6m | 1r | 3r | |
| Výkonn. (%) | +6,93% | +17,84% | +12,81% |
| Výkonn. (abs.) | +9,38 | +21,92 | +16,45 |
| Beta | 0,47 | 0,44 | 0,65 |
| Volatilita | 14,92 | 17,05 | 21,98 |
Stupnice: ABS REL
Nástroj/produkt
Přidat benchmark:
Minulá výkonnost nezaručuje výkonnost budoucí.Zdroj: FactSet
Ceny
| Ø cena 5 dní| Ø objem 5 dní (ks.) | 141,86 EUR (31) |
| Ø cena 30 dní| Ø objem 30 dní (ks.) | 141,87 EUR (26) |
| Ø cena 100 dní| Ø objem 100 dní (ks.) | 143,12 EUR (18) |
| Ø cena 250 dní| Ø objem 250 dní (ks.) | 138,64 EUR (60) |
| YTD Max| datum | 153,80 EUR (20.08.2021) |
| YTD Min | datum | 125,84 EUR (04.01.2021) |
| 52týdenní max. | datum | 153,80 EUR (20.08.2021) |
| 52týdenní min. | datum | 122,40 EUR (08.12.2020) |
Logo společnosti
Kontakty
| JOHNSON & JOHNSON |
| - - |
| One Johnson & Johnson Plaza - 08933 New Brunswick |
| Telefon:1-732-524-0400 |
| Fax:- |
| E-mail:- |
PDF ke stažení
| Report společnosti: JOHNSON & JOHNSON | |
Profil společnosti
Johnson & Johnson is a holding company, which engages in the research and development, manufacture and sale of products in the health care field. It operates through the following segments: Consumer Health, Pharmaceutical, and Medical Devices. The Consumer Health segment includes products used in the baby care, oral care, beauty, over-the-counter pharmaceutical, women's health, and wound care markets. The Pharmaceutical segment focuses on therapeutic areas, such as immunology, infectious diseases, neuroscience, oncology, pulmonary hypertension, and cardiovascular & metabolic diseases. The Medical Devices segment offers products used in the orthopedic, surgery, cardiovascular & neurovascular, and eye health fields. The company was founded by Robert Wood Johnson I, James Wood Johnson and Edward Mead Johnson Sr. in 1886 and is headquartered in New Brunswick, NJ. |
Členové představenstva
| A. Washington | Member of Board of Directors |
| Jennifer Doudna | Member of Board of Directors |
| Mark McClellan | Member of Board of Directors |
| Mary Beckerle | Member of Board of Directors |
| Nadja West | Member of Board of Directors |
| Anne Mulcahy | Member of Board of Directors |
| Charles Prince | Member of Board of Directors |
| D. Davis | Member of Board of Directors |
| Hubert Joly | Member of Board of Directors |
| Ian Davis | Member of Board of Directors |
| Jim Wennerlid | Member of Board of Directors |
| Marillyn Hewson | Member of Board of Directors |
| Mark Weinberger | Member of Board of Directors |
| Ronald Williams | Member of Board of Directors |
| Alex Gorsky (bis 3.01.2022) | Chairman of Managing Board |
| Peter M. Fasolo | Member of Executive Committee |
| Ashley McEvoy | Member of Executive Committee |
| Jennifer Taubert | Member of Executive Committee |
| Joaquin Duato (CEO ab 3.01.2022) | Member of Executive Committee |
| Joseph Wolk | Member of Executive Committee |
| Kathryn E. Wengel | Member of Executive Committee |
| Michael H. Ullmann | Member of Executive Committee |
| Michael Sneed | Member of Executive Committee |
| Paulus Stoffels, M.D. (bis 31.12.2021) | Member of Executive Committee |
| Thibaut Mongon | Member of Executive Committee |